Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle
- PMID: 668810
- DOI: 10.1016/0014-2999(78)90313-8
Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle
Abstract
In animals and man the antidysrhythmic agent disopyramide in primarily metabolised by mono-N-dealkylation. The effects of disopyramide and its N-dealkylated metabolite (MIP) have been investigated using isolated cardiac and nervous tissue, and their effects have been compared with the effects of other antidysrhythmic agents. Disopyramide, d,l-propranolol and quinidine all decreased both maximum driving frequency and developed tension in electrically driven guinea pit atria. MIP and procaine amide also decreased maximum driving frequency, but had a positive intropic effect. MIP was only 4 times less active than disopyramide in decreasing maximum driving frequency. There was no evidence that either disopyramide or MIP possessed beta-adrenoceptor antagonist properties. In superfused rat sciatic nerves, it has been shown that neither disopyramide nor MIP possesses significant local anaesthetic properties. Procaine amide and lignocaine were highly active in this test. The possible contribution of MIP to the actions of disopyramide in vivo is discussed.
Similar articles
-
Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac purkinje fibers. Dependence on underlying cholinergic tone.Circ Res. 1980 May;46(5):660-8. doi: 10.1161/01.res.46.5.660. Circ Res. 1980. PMID: 7363415 No abstract available.
-
Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.Arch Int Pharmacodyn Ther. 1984 Jan;267(1):67-79. Arch Int Pharmacodyn Ther. 1984. PMID: 6721625
-
Disopyramide phosphate: is it just another quinidine.Can J Physiol Pharmacol. 1978 Apr;56(2):326-31. doi: 10.1139/y78-049. Can J Physiol Pharmacol. 1978. PMID: 638888
-
Cardiac effects of disopyramide.Am Heart J. 1976 Oct;92(4):532-6. doi: 10.1016/s0002-8703(76)80054-3. Am Heart J. 1976. PMID: 785992 Review. No abstract available.
-
Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.Angiology. 1978 Mar;29(3):206-42. doi: 10.1177/000331977802900303. Angiology. 1978. PMID: 347988 Review. No abstract available.
Cited by
-
Clinical pharmacokinetics of disopyramide.J Pharmacokinet Biopharm. 1982 Oct;10(5):465-94. doi: 10.1007/BF01059032. J Pharmacokinet Biopharm. 1982. PMID: 6762414 Review. No abstract available.
-
Reliability of antiarrhythmic drug plasma concentration monitoring.Clin Pharmacokinet. 1983 Jan-Feb;8(1):63-82. doi: 10.2165/00003088-198308010-00004. Clin Pharmacokinet. 1983. PMID: 6404580 Review.
-
Clinical pharmacokinetics of disopyramide.Clin Pharmacokinet. 1986 May-Jun;11(3):214-22. doi: 10.2165/00003088-198611030-00003. Clin Pharmacokinet. 1986. PMID: 3524956 Review.
-
Therapeutic drug monitoring of antiarrhythmic drugs.Clin Pharmacokinet. 2003;42(7):647-63. doi: 10.2165/00003088-200342070-00004. Clin Pharmacokinet. 2003. PMID: 12844326 Review.
-
The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.Br J Pharmacol. 1979 Jun;66(2):241-50. doi: 10.1111/j.1476-5381.1979.tb13672.x. Br J Pharmacol. 1979. PMID: 465877 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources